查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888699

心血管治療市場規模、佔有率和趨勢分析報告：按治療類型、適應症、醫療環境、地區和細分市場預測（2025-2033 年）

Cardiovascular Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Indication, By Care Setting, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

心血管市場摘要

2024年全球心血管治療市場規模估計為2,411.8億美元，預計2033年將達到3,831.1億美元。

預計從 2025 年到 2033 年，該市場將以 5.1% 的複合年成長率成長。推動這一市場成長的原因是心血管疾病（CVD）的盛行率不斷上升，例如冠狀動脈疾病、中風、心臟衰竭和高血壓，而這又是由於久坐不動的生活方式、不良的飲食習慣、肥胖以及全球人口老化造成的。

人們對心臟健康和早期診斷意識的提高，以及診斷影像、介入性心臟病學和微創手術技術的進步，正在加速治療方法的普及。藥物釋放型支架、生物可吸收血管支架和新型抗凝血療法等創新技術，正在改善患者預後並拓展臨床應用。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場歷史
    • 母市場分析
    • 相關市場分析
  • 心血管治療市場－市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境工具分析：心血管治療市場
    • 波特五力分析
    • PESTLE分析

第4章：心血管治療市場：依治療類型分類的估算與趨勢分析

  • 按治療類型分類的心血管治療市場：重點
  • 心血管治療市場：按治療類型分類的趨勢和市場佔有率分析（2024 年和 2033 年）
  • 外科手術
    • 冠狀動脈繞道手術手術（CABG）
    • 閥門維修/置換術
    • 心臟移植手術
    • 其他
  • 介入性手術
    • 經皮冠狀動脈介入治療（PCI）
    • 血管成形術
    • 經導管主動脈瓣置換術（TAVR）
    • 其他
  • 非侵入性手術
    • 心臟復健
    • 物理治療和生活方式調整
    • 其他

第5章：心血管治療市場：依適應症分類的估算與趨勢分析

  • 心血管治療市場依適應症分類：重點
  • 心血管治療市場：適應症變化分析與市佔率分析（2024 年和 2033 年）
  • 缺血性心臟疾病（IHD）
  • 心臟衰竭和心肌病
  • 心律不整和傳導障礙
  • 結構性和瓣膜性心臟疾病
  • 其他

第6章：心血管治療市場：醫療環境估算與趨勢分析

  • 按醫療機構分類的心血管治療市場：要點
  • 心血管治療市場：醫療環境與市佔率變化分析（2024 年和 2033 年）
  • 醫院
  • 門診設施

第7章：心血管治療市場：區域估算與趨勢分析

  • 2024 年及 2033 年區域市佔率分析
  • 區域市場概覽
  • 全球市場概覽（按地區分類）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 對主要市場參與企業近期趨勢和影響的分析
  • 公司/競爭對手分類
  • 主要企業市場分析，2024 年
  • 公司列表
    • The Johns Hopkins Hospital
    • Cleveland Clinic
    • Icahn School of Medicine at Mount Sinai
    • Toronto General Hospital (University Health Network)
    • Sagar Hospitals
    • Sagar Hospitals
    • Medanta The Medicity
    • The University of Tokyo Hospital
    • Royal Papworth Hospital NHS Foundation Trust
    • London Bridge Hospital (HCA Healthcare UK)
    • Burjeel Hospital
    • King's College Hospital NHS Foundation Trust
    • Beneficente Israelita Brasileira Albert Einstein
Product Code: GVR-4-68040-816-6

Cardiovascular Treatment Market Summary

The global cardiovascular treatment market size was estimated at USD 241.18 billion in 2024 and is projected to reach USD 383.11 billion by 2033, growing at a CAGR of 5.1% from 2025 to 2033. This market growth is driven by the rising prevalence of cardiovascular diseases (CVDs) such as coronary artery disease, stroke, heart failure, and hypertension, fueled by sedentary lifestyles, poor dietary habits, obesity, and an aging global population.

Increasing awareness of heart health and early diagnosis, coupled with advancements in diagnostic imaging, interventional cardiology, and minimally invasive surgical techniques, accelerating treatment adoption. Moreover, technological innovations such as drug-eluting stents, bioresorbable vascular scaffolds, and novel anticoagulant therapies are enhancing patient outcomes and expanding clinical applications.

Global Cardiovascular Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cardiovascular treatment market report based on treatment type, indication, care setting, and region.

  • Treatment Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Surgical Procedures
    • Coronary Artery Bypass Grafting (CABG)
    • Valve Repair/Replacement
    • Heart Transplant Surgery
    • Others
  • Interventional Procedures
    • Percutaneous Coronary Intervention (PCI)
    • Angioplasty
    • Transcatheter Aortic Valve Replacement (TAVR)
    • Others
  • Non-invasive Procedures
    • Cardiac Rehabilitation
    • Physical Therapy and Lifestyle Intervention
    • Others
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Ischemic Heart Disease (IHD)
  • Heart Failure & Cardiomyopathies
  • Cardiac Arrhythmias & Conduction Disorders
  • Structural Heart & Valvular Disease
  • Others
  • Care Setting Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Outpatient Facilities
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
    • 1.5.1. Commodity Flow Analysis
  • 1.6. Data Validation & Publishing
  • 1.7. List of Secondary Sources
  • 1.8. Research Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

  • 3.1. Market Lineage
    • 3.1.1. Parent Market Analysis
    • 3.1.2. Ancillary Market Analysis
  • 3.2. Cardiovascular Treatment Market- Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environmental Tools Analysis: Cardiovascular Treatment Market
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTLE Analysis

Chapter 4. Cardiovascular Treatment Market: Treatment Type Estimates & Trend Analysis

  • 4.1. Cardiovascular Treatment Market, By Treatment Type: Key Takeaways
  • 4.2. Cardiovascular Treatment Market: Treatment Type Movement & Market Share Analysis, 2024 & 2033
  • 4.3. Surgical Procedures
    • 4.3.1. Surgical Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Coronary Artery Bypass Grafting (CABG)
      • 4.3.2.1. Coronary Artery Bypass Grafting (CABG) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Valve Repair/Replacement
      • 4.3.3.1. Valve Repair/Replacement Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Heart Transplant Surgery
      • 4.3.4.1. Heart Transplant Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.5. Others
      • 4.3.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Interventional Procedures
    • 4.4.1. Interventional Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Percutaneous Coronary Intervention (PCI)
      • 4.4.2.1. Percutaneous Coronary Intervention (PCI) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Angioplasty
      • 4.4.3.1. Angioplasty Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Transcatheter Aortic Valve Replacement (TAVR)
      • 4.4.4.1. Transcatheter Aortic Valve Replacement (TAVR) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Non-invasive Procedures
    • 4.5.1. Non-invasive Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Cardiac Rehabilitation
      • 4.5.2.1. Cardiac Rehabilitation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Physical Therapy and Lifestyle Intervention
      • 4.5.3.1. Physical Therapy and Lifestyle Intervention Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Cardiovascular Treatment Market: Indication Estimates & Trend Analysis

  • 5.1. Cardiovascular Treatment Market, By Indication: Key Takeaways
  • 5.2. Cardiovascular Treatment Market: Indication Movement & Market Share Analysis, 2024 & 2033
  • 5.3. Ischemic Heart Disease (IHD)
    • 5.3.1. Ischemic Heart Disease (IHD) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Heart Failure & Cardiomyopathies
    • 5.4.1. Heart Failure & Cardiomyopathies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Cardiac Arrhythmias & Conduction Disorders
    • 5.5.1. Cardiac Arrhythmias & Conduction Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Structural Heart & Valvular Disease
    • 5.6.1. Structural Heart & Valvular Disease Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Cardiovascular Treatment Market: Care Setting Estimates & Trend Analysis

  • 6.1. Cardiovascular Treatment Market, By Care Setting: Key Takeaways
  • 6.2. Cardiovascular Treatment Market: Care Setting Movement & Market Share Analysis, 2024 & 2033
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Outpatient Facilities
    • 6.4.1. Outpatient Facilities Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Cardiovascular Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market position analysis, 2024
  • 8.4. List of Companies
    • 8.4.1. The Johns Hopkins Hospital
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Service benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Cleveland Clinic
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Service benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Icahn School of Medicine at Mount Sinai
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Service benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Toronto General Hospital (University Health Network)
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Service benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Sagar Hospitals
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Service benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Sagar Hospitals
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Service benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Medanta The Medicity
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Service benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. The University of Tokyo Hospital
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Service benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Royal Papworth Hospital NHS Foundation Trust
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Service benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. London Bridge Hospital (HCA Healthcare UK)
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Service benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Burjeel Hospital
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Service benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. King's College Hospital NHS Foundation Trust
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Service benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Beneficente Israelita Brasileira Albert Einstein
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Service benchmarking
      • 8.4.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 3 Global cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 4 Global cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 5 Global cardiovascular treatment market, by region, 2021 - 2033 (USD Million)
  • Table 6 North America cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 7 North America cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 8 North America cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 9 North America cardiovascular treatment market, by country, 2021 - 2033 (USD Million)
  • Table 10 U.S. cardiovascular treatment market, by procedure, 2021 - 2033 (USD Million)
  • Table 11 U.S. cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 12 U.S. cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 13 Canada cardiovascular treatment market, by procedure, 2021 - 2033 (USD Million)
  • Table 14 Canada cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 15 Canada cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 16 Europe cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 17 Europe cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 18 Europe cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 19 Europe cardiovascular treatment market, by country, 2021 - 2033 (USD Million)
  • Table 20 UK cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 21 UK cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 22 UK cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 23 UK cardiovascular treatment market, by region, 2021 - 2033 (USD Million)
  • Table 24 Germany cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 25 Germany cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 26 Germany cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 27 France cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 28 France cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 29 France cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 30 Italy cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 31 Italy cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 32 Italy cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 33 Spain cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 34 Spain cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 35 Spain cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 36 Sweden cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 37 Sweden cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 38 Sweden cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 39 Norway cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 40 Norway cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 41 Norway cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 42 Denmark cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 43 Denmark cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 44 Denmark cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific cardiovascular treatment market, by country, 2021 - 2033 (USD Million)
  • Table 49 China cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 50 China cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 51 China cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 52 Japan cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 53 Japan cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 54 Japan cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 55 India cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 56 India cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 57 India cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 58 Australia cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 59 Australia cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 60 Australia cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 61 Thailand cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 62 Thailand cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 63 Thailand cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 64 South Korea cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 65 South Korea cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 66 South Korea cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 67 Latin America cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 68 Latin America cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 69 Latin America cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 70 Latin America cardiovascular treatment market, by country, 2021 - 2033 (USD Million)
  • Table 71 Brazil cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 72 Brazil cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 73 Brazil cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 74 Mexico cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 75 Mexico cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 76 Mexico cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 77 Argentina cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 78 Argentina cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 79 Argentina cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 80 Middle East and Africa cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 81 Middle East and Africa cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 82 Middle East and Africa cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 83 Middle East and Africa cardiovascular treatment market, by country, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 87 South Africa cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 88 South Africa cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 89 South Africa cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 90 UAE cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 91 UAE cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 92 UAE cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)
  • Table 93 Kuwait cardiovascular treatment market, by treatment type, 2021 - 2033 (USD Million)
  • Table 94 Kuwait cardiovascular treatment market, by indication, 2021 - 2033 (USD Million)
  • Table 95 Kuwait cardiovascular treatment market, by care setting, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Cardiovascular treatment: market outlook
  • Fig. 9 Cardiovascular treatment competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Cardiovascular treatment market driver impact
  • Fig. 15 Cardiovascular treatment market restraint impact
  • Fig. 16 Cardiovascular treatment market strategic initiatives analysis
  • Fig. 17 Cardiovascular treatment market: Treatment type movement analysis
  • Fig. 18 Cardiovascular treatment market: Treatment type outlook and key takeaways
  • Fig. 19 Surgical procedures market estimates and forecasts, 2021 - 2033
  • Fig. 20 Coronary artery bypass grafting (CABG) market estimates and forecasts, 2021 - 2033
  • Fig. 21 Valve repair/replacement market estimates and forecasts, 2021 - 2033
  • Fig. 22 Heart transplant surgery market estimates and forecasts, 2021 - 2033
  • Fig. 23 Other surgical procedures market estimates and forecasts, 2021 - 2033
  • Fig. 24 Interventional procedures market estimates and forecasts, 2021 - 2033
  • Fig. 25 Percutaneous coronary intervention (PCI) market estimates and forecasts, 2021 - 2033
  • Fig. 26 Angioplasty market estimates and forecasts, 2021 - 2033
  • Fig. 27 Transcatheter aortic valve replacement (TAVR) market estimates and forecasts, 2021 - 2033
  • Fig. 28 Other interventional procedures market estimates and forecasts, 2021 - 2033
  • Fig. 29 Non-invasive procedures market estimates and forecasts, 2021 - 2033
  • Fig. 30 Cardiac rehabilitation market estimates and forecasts, 2021 - 2033
  • Fig. 31 Physical therapy and lifestyle intervention market estimates and forecasts, 2021 - 2033
  • Fig. 32 Other non-invasive procedures market estimates and forecasts, 2021 - 2033
  • Fig. 33 Cardiovascular treatment market: Indication movement analysis
  • Fig. 34 Cardiovascular treatment market: Indication outlook and key takeaways
  • Fig. 35 Ischemic heart disease (IHD) market estimates and forecasts, 2021 - 2033
  • Fig. 36 Heart failure & cardiomyopathies market estimates and forecasts, 2021 - 2033
  • Fig. 37 Cardiac arrhythmias & conduction disorders market estimates and forecasts, 2021 - 2033
  • Fig. 38 Structural heart & valvular disease market estimates and forecasts, 2021 - 2033
  • Fig. 39 Other indications market estimates and forecasts, 2021 - 2033
  • Fig. 40 Cardiovascular treatment market: Care setting movement analysis
  • Fig. 41 Cardiovascular treatment market: Care setting outlook and key takeaways
  • Fig. 42 Hospitals market estimates and forecasts, 2021 - 2033
  • Fig. 43 Outpatient care market estimates and forecasts, 2021 - 2033
  • Fig. 44 Global cardiovascular treatment market: Regional movement analysis
  • Fig. 45 Global cardiovascular treatment market: Regional outlook and key takeaways
  • Fig. 46 North America market estimates and forecasts, 2021 - 2033
  • Fig. 47 U.S. market estimates and forecasts, 2021 - 2033
  • Fig. 48 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 49 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 50 UK market estimates and forecasts, 2021 - 2033
  • Fig. 51 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 52 France market estimates and forecasts, 2021 - 2033
  • Fig. 53 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 54 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 55 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 56 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 57 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 58 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 59 China market estimates and forecasts, 2021 - 2033
  • Fig. 60 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 61 India market estimates and forecasts, 2021 - 2033
  • Fig. 62 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 63 Thailand market estimates and forecasts, 2021 - 2033
  • Fig. 64 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 65 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 66 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 67 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 68 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 69 Middle East & Africa market estimates and forecasts, 2021 - 2033
  • Fig. 70 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 71 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 72 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 73 Kuwait market estimates and forecasts, 2021 - 2033
  • Fig. 74 Strategy framework